<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on May 15, 2026 at 1:42 PM by All in One SEO v4.9.7.1 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://cgxpwire.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>cGxP.wire</title>
		<link><![CDATA[https://cgxpwire.com]]></link>
		<description><![CDATA[cGxP.wire]]></description>
		<lastBuildDate><![CDATA[Fri, 15 May 2026 06:49:08 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://cgxpwire.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/nurix-shows-promising-csu-data-for-bexobrutideg/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/nurix-shows-promising-csu-data-for-bexobrutideg/]]></link>
			<title>Nurix Shows Promising CSU Data for Bexobrutideg</title>
			<pubDate><![CDATA[Fri, 15 May 2026 06:49:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/editas-medicine-shows-durable-ldl-c-reduction-with-edit-401/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/editas-medicine-shows-durable-ldl-c-reduction-with-edit-401/]]></link>
			<title>Editas Medicine Shows Durable LDL-C Reduction With EDIT-401</title>
			<pubDate><![CDATA[Fri, 15 May 2026 06:32:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/aviadobio-advances-avb-406-gene-therapy-for-alzheimers/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/aviadobio-advances-avb-406-gene-therapy-for-alzheimers/]]></link>
			<title>AviadoBio Advances AVB-406 Gene Therapy for Alzheimer’s</title>
			<pubDate><![CDATA[Fri, 15 May 2026 06:27:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/mirai-bio-expands-lnp-delivery-into-adipocyte-tissue/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/mirai-bio-expands-lnp-delivery-into-adipocyte-tissue/]]></link>
			<title>Mirai Bio Expands LNP Delivery Into Adipocyte Tissue</title>
			<pubDate><![CDATA[Fri, 15 May 2026 06:17:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/osel-launches-phase-2b-trial-for-preterm-birth-prevention/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/osel-launches-phase-2b-trial-for-preterm-birth-prevention/]]></link>
			<title>Osel Launches Phase 2b Trial for Preterm Birth Prevention</title>
			<pubDate><![CDATA[Fri, 15 May 2026 06:04:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/mergers-acquisitions/zydus-lifesciences-to-acquire-assertio-in-166-4-million-deal/]]></guid>
			<link><![CDATA[https://cgxpwire.com/mergers-acquisitions/zydus-lifesciences-to-acquire-assertio-in-166-4-million-deal/]]></link>
			<title>Zydus Lifesciences to Acquire Assertio in $166.4 Million Deal</title>
			<pubDate><![CDATA[Fri, 15 May 2026 05:29:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/mergers-acquisitions/fosun-pharma-signs-global-option-deal-for-aribios-ar1001/]]></guid>
			<link><![CDATA[https://cgxpwire.com/mergers-acquisitions/fosun-pharma-signs-global-option-deal-for-aribios-ar1001/]]></link>
			<title>Fosun Pharma Signs Global Option Deal for AriBio’s AR1001</title>
			<pubDate><![CDATA[Fri, 15 May 2026 05:15:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/sahin-and-tureci-honored-for-vaccine-innovation/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/sahin-and-tureci-honored-for-vaccine-innovation/]]></link>
			<title>Şahin and Türeci Honored for Vaccine Innovation</title>
			<pubDate><![CDATA[Fri, 15 May 2026 04:45:23 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/arup-laboratories-launches-national-disease-trends-dashboard/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/arup-laboratories-launches-national-disease-trends-dashboard/]]></link>
			<title>ARUP Laboratories Launches National Disease Trends Dashboard</title>
			<pubDate><![CDATA[Fri, 15 May 2026 04:40:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/government/taiho-oncology-wins-fda-approval-for-inqovi-combo/]]></guid>
			<link><![CDATA[https://cgxpwire.com/government/taiho-oncology-wins-fda-approval-for-inqovi-combo/]]></link>
			<title>Taiho Oncology Wins FDA Approval for INQOVI Combo</title>
			<pubDate><![CDATA[Fri, 15 May 2026 04:35:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/icon-expands-us-early-phase-research-network-in-texas/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/icon-expands-us-early-phase-research-network-in-texas/]]></link>
			<title>ICON Expands US Early Phase Research Network in Texas</title>
			<pubDate><![CDATA[Fri, 15 May 2026 04:29:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/technology/tekniplex-healthcare-highlights-ppwr-ready-blister-packaging-solutions/]]></guid>
			<link><![CDATA[https://cgxpwire.com/technology/tekniplex-healthcare-highlights-ppwr-ready-blister-packaging-solutions/]]></link>
			<title>TekniPlex Healthcare Highlights PPWR-Ready Blister Packaging Solutions</title>
			<pubDate><![CDATA[Fri, 15 May 2026 04:18:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/angiodynamics-nanoknife-shows-durable-prostate-cancer-control/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/angiodynamics-nanoknife-shows-durable-prostate-cancer-control/]]></link>
			<title>AngioDynamics NanoKnife Shows Durable Prostate Cancer Control</title>
			<pubDate><![CDATA[Fri, 15 May 2026 04:13:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/government/lupin-wins-u-s-fda-approval-for-famotidine-injection/]]></guid>
			<link><![CDATA[https://cgxpwire.com/government/lupin-wins-u-s-fda-approval-for-famotidine-injection/]]></link>
			<title>Lupin Wins U.S. FDA Approval for Famotidine Injection</title>
			<pubDate><![CDATA[Fri, 15 May 2026 03:51:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/nuvation-bio-partners-with-thermo-fisher-for-u-s-production-of-ibtrozi/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/nuvation-bio-partners-with-thermo-fisher-for-u-s-production-of-ibtrozi/]]></link>
			<title>Nuvation Bio Partners With Thermo Fisher for U.S. Production of IBTROZI</title>
			<pubDate><![CDATA[Fri, 15 May 2026 03:42:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/lilly-partners-with-unicef-to-expand-pediatric-healthcare-access/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/lilly-partners-with-unicef-to-expand-pediatric-healthcare-access/]]></link>
			<title>Lilly Partners With UNICEF to Expand Pediatric Healthcare Access</title>
			<pubDate><![CDATA[Fri, 15 May 2026 03:31:23 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/gemmabio-expands-gene-therapy-pipeline-for-rare-diseases/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/gemmabio-expands-gene-therapy-pipeline-for-rare-diseases/]]></link>
			<title>GEMMABio Expands Gene Therapy Pipeline for Rare Diseases</title>
			<pubDate><![CDATA[Fri, 15 May 2026 03:24:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/beone-medicines-wins-fda-approval-for-beqalzi-in-mantle-cell-lymphoma/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/beone-medicines-wins-fda-approval-for-beqalzi-in-mantle-cell-lymphoma/]]></link>
			<title>BeOne Medicines Wins FDA Approval for BEQALZI in Mantle Cell Lymphoma</title>
			<pubDate><![CDATA[Thu, 14 May 2026 06:25:24 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/resurge-reports-positive-bph-ipde-clinical-results/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/resurge-reports-positive-bph-ipde-clinical-results/]]></link>
			<title>Resurge Reports Positive BPH IPDE Clinical Results</title>
			<pubDate><![CDATA[Fri, 15 May 2026 03:17:49 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/exero-medical-highlights-fda-breakthrough-xbar-study-at-ascrs-2026/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/exero-medical-highlights-fda-breakthrough-xbar-study-at-ascrs-2026/]]></link>
			<title>Exero Medical Highlights FDA Breakthrough xBar Study at ASCRS 2026</title>
			<pubDate><![CDATA[Wed, 13 May 2026 11:11:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/apotex-launches-generic-ozempic-alternative-in-canada/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/apotex-launches-generic-ozempic-alternative-in-canada/]]></link>
			<title>Apotex Launches Generic Ozempic Alternative in Canada</title>
			<pubDate><![CDATA[Fri, 15 May 2026 06:56:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/encoded-therapeutics-expands-cns-gene-therapy-pipeline/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/encoded-therapeutics-expands-cns-gene-therapy-pipeline/]]></link>
			<title>Encoded Therapeutics Expands CNS Gene Therapy Pipeline</title>
			<pubDate><![CDATA[Wed, 13 May 2026 06:32:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/eli-lilly-strengthens-glp-1-leadership-with-new-foundayo-trial-results/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/eli-lilly-strengthens-glp-1-leadership-with-new-foundayo-trial-results/]]></link>
			<title>Eli Lilly Strengthens GLP-1 Leadership With New Foundayo Trial Results</title>
			<pubDate><![CDATA[Wed, 13 May 2026 06:23:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/phio-pharmaceuticals-showcases-ph-762-skin-cancer-trial-progress/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/phio-pharmaceuticals-showcases-ph-762-skin-cancer-trial-progress/]]></link>
			<title>Phio Pharmaceuticals Showcases PH-762 Skin Cancer Trial Progress</title>
			<pubDate><![CDATA[Thu, 14 May 2026 05:43:24 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/encoded-therapeutics-reports-strong-etx101-results/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/encoded-therapeutics-reports-strong-etx101-results/]]></link>
			<title>Encoded Therapeutics Reports Strong ETX101 Results</title>
			<pubDate><![CDATA[Thu, 14 May 2026 05:33:35 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/bioinvent-highlights-bi-1206-nhl-combination-data-at-eha/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/bioinvent-highlights-bi-1206-nhl-combination-data-at-eha/]]></link>
			<title>BioInvent Highlights BI-1206 NHL Combination Data at EHA</title>
			<pubDate><![CDATA[Thu, 14 May 2026 05:13:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/sana-biotechnology-advances-in-vivo-car-t-platform/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/sana-biotechnology-advances-in-vivo-car-t-platform/]]></link>
			<title>Sana Biotechnology Advances In Vivo CAR T Platform</title>
			<pubDate><![CDATA[Thu, 14 May 2026 04:42:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/andzonbio2-and-cambridge-partner-on-neuroinflammation-therapies/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/andzonbio2-and-cambridge-partner-on-neuroinflammation-therapies/]]></link>
			<title>AndzonBio2 and Cambridge Partner on Neuroinflammation Therapies</title>
			<pubDate><![CDATA[Thu, 14 May 2026 04:40:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/kelun-biotech-gains-china-ind-clearance-for-skb118/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/kelun-biotech-gains-china-ind-clearance-for-skb118/]]></link>
			<title>Kelun-Biotech Gains China IND Clearance for SKB118</title>
			<pubDate><![CDATA[Thu, 14 May 2026 04:27:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/renerva-implants-first-pnm-cap-device-for-neuroma-pain/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/renerva-implants-first-pnm-cap-device-for-neuroma-pain/]]></link>
			<title>Renerva Implants First PNM-CAP Device for Neuroma Pain</title>
			<pubDate><![CDATA[Thu, 14 May 2026 04:21:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/innovent-highlights-obesity-pipeline-at-ada-2026/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/innovent-highlights-obesity-pipeline-at-ada-2026/]]></link>
			<title>Innovent Highlights Obesity Pipeline at ADA 2026</title>
			<pubDate><![CDATA[Thu, 14 May 2026 04:16:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/neurogene-highlights-rett-gene-therapy-progress-at-asgct/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/neurogene-highlights-rett-gene-therapy-progress-at-asgct/]]></link>
			<title>Neurogene Highlights Rett Gene Therapy Progress at ASGCT</title>
			<pubDate><![CDATA[Wed, 13 May 2026 06:40:39 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/astellas-reports-izervay-reduced-vision-decline-in-ga-patients/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/astellas-reports-izervay-reduced-vision-decline-in-ga-patients/]]></link>
			<title>Astellas Reports IZERVAY Reduced Vision Decline in GA Patients</title>
			<pubDate><![CDATA[Thu, 14 May 2026 04:11:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/ascentage-pharma-highlights-hematology-pipeline-at-eha/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/ascentage-pharma-highlights-hematology-pipeline-at-eha/]]></link>
			<title>Ascentage Pharma Highlights Hematology Pipeline at EHA</title>
			<pubDate><![CDATA[Thu, 14 May 2026 04:10:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/andelyn-biosciences-earns-icmc-gene-therapy-certification/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/andelyn-biosciences-earns-icmc-gene-therapy-certification/]]></link>
			<title>Andelyn Biosciences Earns ICMC Gene Therapy Certification</title>
			<pubDate><![CDATA[Thu, 14 May 2026 04:02:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/delfi-diagnostics-expands-blood-based-lung-screening/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/delfi-diagnostics-expands-blood-based-lung-screening/]]></link>
			<title>DELFI Diagnostics Expands Blood-Based Lung Screening</title>
			<pubDate><![CDATA[Thu, 14 May 2026 03:48:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/cepheid-gains-ivdr-ce-mark-for-xpert-gi-panel/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/cepheid-gains-ivdr-ce-mark-for-xpert-gi-panel/]]></link>
			<title>Cepheid Gains IVDR CE Mark for Xpert GI Panel</title>
			<pubDate><![CDATA[Thu, 14 May 2026 03:40:43 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/astrazeneca-reports-positive-phase-iii-results-for-eneboparatide-in-hypopt/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/astrazeneca-reports-positive-phase-iii-results-for-eneboparatide-in-hypopt/]]></link>
			<title>AstraZeneca Reports Positive Phase III Results for Eneboparatide in HypoPT</title>
			<pubDate><![CDATA[Thu, 14 May 2026 03:39:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/venture-capital-fund/isomorphic-labs-raises-2-1b-for-ai-drug-discovery/]]></guid>
			<link><![CDATA[https://cgxpwire.com/venture-capital-fund/isomorphic-labs-raises-2-1b-for-ai-drug-discovery/]]></link>
			<title>Isomorphic Labs Raises $2.1B for AI Drug Discovery</title>
			<pubDate><![CDATA[Thu, 14 May 2026 03:39:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/enliven-therapeutics-reports-strong-elvn-001-cml-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/enliven-therapeutics-reports-strong-elvn-001-cml-data/]]></link>
			<title>Enliven Therapeutics Reports Strong ELVN-001 CML Data</title>
			<pubDate><![CDATA[Thu, 14 May 2026 03:38:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/pfizer-wins-eu-approval-for-hympavzi-in-hemophilia/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/pfizer-wins-eu-approval-for-hympavzi-in-hemophilia/]]></link>
			<title>Pfizer Wins EU Approval for HYMPAVZI in Hemophilia</title>
			<pubDate><![CDATA[Thu, 14 May 2026 03:37:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/medicenna-advances-mdna11-melanoma-trial-in-italy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/medicenna-advances-mdna11-melanoma-trial-in-italy/]]></link>
			<title>Medicenna Advances MDNA11 Melanoma Trial in Italy</title>
			<pubDate><![CDATA[Wed, 13 May 2026 06:21:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/askbio-expands-rare-disease-pipeline-with-ab-1009-pompe-trial-milestone/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/askbio-expands-rare-disease-pipeline-with-ab-1009-pompe-trial-milestone/]]></link>
			<title>AskBio Expands Rare Disease Pipeline With AB-1009 Pompe Trial Milestone</title>
			<pubDate><![CDATA[Wed, 13 May 2026 05:52:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/bioinvent-reports-strong-bi-1808-ctcl-responses-at-eha/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/bioinvent-reports-strong-bi-1808-ctcl-responses-at-eha/]]></link>
			<title>BioInvent Reports Strong BI-1808 CTCL Responses at EHA</title>
			<pubDate><![CDATA[Thu, 14 May 2026 05:04:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/airna-showcases-rna-editing-advances-at-asgct-2026/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/airna-showcases-rna-editing-advances-at-asgct-2026/]]></link>
			<title>AIRNA Showcases RNA Editing Advances at ASGCT 2026</title>
			<pubDate><![CDATA[Wed, 13 May 2026 05:50:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/enlitic-expands-ai-radiology-platform-into-new-zealand/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/enlitic-expands-ai-radiology-platform-into-new-zealand/]]></link>
			<title>Enlitic Expands AI Radiology Platform Into New Zealand</title>
			<pubDate><![CDATA[Wed, 13 May 2026 05:46:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/nurix-therapeutics-showcases-bexobrutideg-data-at-eha/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/nurix-therapeutics-showcases-bexobrutideg-data-at-eha/]]></link>
			<title>Nurix Therapeutics Showcases Bexobrutideg Data at EHA</title>
			<pubDate><![CDATA[Thu, 14 May 2026 04:49:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/definium-therapeutics-begins-phase-3-dt120-odt-study/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/definium-therapeutics-begins-phase-3-dt120-odt-study/]]></link>
			<title>Definium Therapeutics Begins Phase 3 DT120-ODT Study</title>
			<pubDate><![CDATA[Wed, 13 May 2026 05:38:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/mergers-acquisitions/boehringer-expands-immunology-pipeline-with-immunitas-deal/]]></guid>
			<link><![CDATA[https://cgxpwire.com/mergers-acquisitions/boehringer-expands-immunology-pipeline-with-immunitas-deal/]]></link>
			<title>Boehringer Expands Immunology Pipeline With Immunitas Deal</title>
			<pubDate><![CDATA[Wed, 13 May 2026 05:37:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/meiji-seika-reports-positive-phase-iii-nacubactam-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/meiji-seika-reports-positive-phase-iii-nacubactam-data/]]></link>
			<title>Meiji Seika Reports Positive Phase III Nacubactam Data</title>
			<pubDate><![CDATA[Fri, 15 May 2026 07:08:12 +0000]]></pubDate>
		</item>
				</channel>
</rss>
